Correlation Between TC BioPharm and Gogoro Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TC BioPharm and Gogoro Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TC BioPharm and Gogoro Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TC BioPharm Holdings and Gogoro Equity Warrant, you can compare the effects of market volatilities on TC BioPharm and Gogoro Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TC BioPharm with a short position of Gogoro Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of TC BioPharm and Gogoro Equity.

Diversification Opportunities for TC BioPharm and Gogoro Equity

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between TCBP and Gogoro is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding TC BioPharm Holdings and Gogoro Equity Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gogoro Equity Warrant and TC BioPharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TC BioPharm Holdings are associated (or correlated) with Gogoro Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gogoro Equity Warrant has no effect on the direction of TC BioPharm i.e., TC BioPharm and Gogoro Equity go up and down completely randomly.

Pair Corralation between TC BioPharm and Gogoro Equity

Given the investment horizon of 90 days TC BioPharm Holdings is expected to under-perform the Gogoro Equity. But the stock apears to be less risky and, when comparing its historical volatility, TC BioPharm Holdings is 5.33 times less risky than Gogoro Equity. The stock trades about -0.09 of its potential returns per unit of risk. The Gogoro Equity Warrant is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  40.00  in Gogoro Equity Warrant on August 31, 2024 and sell it today you would lose (37.97) from holding Gogoro Equity Warrant or give up 94.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy97.06%
ValuesDaily Returns

TC BioPharm Holdings  vs.  Gogoro Equity Warrant

 Performance 
       Timeline  
TC BioPharm Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TC BioPharm Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Gogoro Equity Warrant 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Gogoro Equity Warrant are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Gogoro Equity showed solid returns over the last few months and may actually be approaching a breakup point.

TC BioPharm and Gogoro Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TC BioPharm and Gogoro Equity

The main advantage of trading using opposite TC BioPharm and Gogoro Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TC BioPharm position performs unexpectedly, Gogoro Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gogoro Equity will offset losses from the drop in Gogoro Equity's long position.
The idea behind TC BioPharm Holdings and Gogoro Equity Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk